CONGENITAL ADRENAL HYPERPLASIA: CALCIUM CHANNELS AS THERAPEUTIC TARGETS

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will test the ability of amlodipine, a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication currently taking to treat CAH